Pharmaceutical industry
Information on the European Medicines Agency’s (EMA) activities that are of particular relevance to stakeholders from the pharmaceutical industry
Latvian is available via eTranslation, the European Commission's machine translation service.
Translate to Latvian | Important information about machine translation
The pharmaceutical industry and medical device industry associations in the European Union (EU) are some of EMA's main stakeholders.
Interacting with pharmaceutical companies has been a major part of EMA's daily business since it began operating. Since 2022, EMA has also interacted with medical device companies, in line with EMA's extended mandate for dealing with public health emergencies.
EMA's contacts with these stakeholders are guided by a formal framework that rests on the principles of accountability, transparency and broad representation.
Working with pharmaceutical industry stakeholders
Framework for interaction
EMA's framework for interaction with pharmaceutical industry associations active in the human and veterinary medicines sectors, as well as reports on these interactions
Getting involved in EMA activities
Eligibility criteria, application process and list of industry stakeholder organisations involved in EMA activities
Industry Standing Group
The Industry Standing Group (ISG) enables regular dialogue with industry stakeholders on issues relating to human medicines and medical devices. The group also facilitates the implementation of new legislation in the EU
Industry stakeholder platform meetings
Meetings with representatives of the pharmaceutical industry to address operational aspects linked to research and development for medicines, the centralised marketing authorisation procedure and pharmacovigilance
Industry bilateral meetings
The purpose of the annual bilateral meetings with pharmaceutical industry associations is to exchange views and promote dialogue on high level and strategic topics of common interest
Image credit: © Tierney | stock.adobe.com
Featured topics from our website
Human regulatory: overview
Information on the regulation of medicines for human use in the EU, with a focus on the centralised procedure
Veterinary regulatory: overview
Information on the regulation of veterinary medicines in the EU, with a focus on the centralised procedure
Medical devices
EMA's regulatory responsibilities for medical devices in the EU
Support to SMEs
The dedicated SME office addresses the specific needs of smaller pharmaceutical companies, with the aim of promoting innovation and development of new human and veterinary medicines
Supporting innovation
A range of services is available from EMA, Heads of Medicines Agencies (HMA) and European Commission to support innovative medicines and associated technology developments in the EU
What's new
All new and updated information published on our website in one place
What we publish on medicines and when
Information on what EMA publishes and when for human and veterinary medicines, as well as publication times and locations
Download medicine data
You can download data related to medicines published on EMA's website in table format. The website automatically updates these data tables overnight
Stay updated on the latest regulatory and policy developments impacting the pharmaceutical industry and requiring action.
The newsletter focuses on:
- Implementation of legislative and regulatory requirements
- Initiatives fostering innovation
- Initiatives strengthening industry competitiveness
EMA contact points for pharmaceutical and medical device industries
EMA's Public and Stakeholders Engagement Department, set up in 2014, acts as a central contact point dedicated to consolidating, streamlining and coordinating EMA's relations and communication activities with stakeholder organisations.
EMA stakeholders include industry associations representing pharmaceutical and medical device companies.
Industry stakeholders can get in touch via EMAindustryliaison@ema.europa.eu.